Contract facts
FederalNo full NAICS 334516 intel page yet. Browse NAICS intelligence
OY3 BLANKET PURCHASE AGREEMENT FOR CHEMISTRY COST PER REPORTABLE is a federal award for Network Contract Office 23 (36C263) held by Ortho-Clinical Diagnostics, Inc. Estimated value $210K ($-190,077.14 obligated). Current period of performance ends Sep 30, 2021 (potential Sep 30, 2022). Place of performance: FORT MEADE SD.
OY3 BLANKET PURCHASE AGREEMENT FOR CHEMISTRY COST PER REPORTABLE
Recompete timing
PublicCurrent PoP ended Sep 30, 2021 (1787 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Incumbent footprint
Public recordOrtho-Clinical Diagnostics, Inc — $57.6M obligated across 1,615 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 36C26321N0170?
36C26321N0170 (Oy3 blanket purchase agreement for chemistry) is a Network Contract Office 23 (36C263) award with a potential value of $210K, currently held by Ortho-Clinical Diagnostics, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is 36C263-21-N-0170?
36C263-21-N-0170 is the dashed form of PIID 36C26321N0170 (Oy3 blanket purchase agreement for chemistry), held by Ortho-Clinical Diagnostics, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded 36C26321N0170?
Network Contract Office 23 (36C263) awarded 36C26321N0170 to Ortho-Clinical Diagnostics, Inc (potential $210K).
Who is the incumbent on 36C26321N0170?
Ortho-Clinical Diagnostics, Inc is the incumbent with $57.6M across 1615 related awards in SCOUT’s public footprint. The current period of performance ends Sep 30, 2021.
When does Ortho-Clinical Diagnostics, Inc’s 36C26321N0170 come up for recompete?
SCOUT tracks a period-of-performance end of Sep 30, 2021. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.